NASH - NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for advanced fatty liver: new drug trial targets cirrhosis
Disease control Recruiting nowThis study tests a new medicine called efruxifermin for people with advanced liver scarring (cirrhosis) caused by fatty liver disease (NASH/MASH). About 2,150 adults will receive either the drug or a placebo to see if it prevents serious liver events like liver failure. The goal …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Can surgery beat diet for fatty liver? new study aims to find out
Disease control Recruiting nowThis study tests whether adding weight-loss surgery (vertical sleeve gastrectomy) to lifestyle changes is better than lifestyle changes alone for treating NASH, a serious fatty liver disease. About 48 adults aged 30-70 with NASH and obesity will be randomly assigned to one of two…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
Can Weight-Loss surgery reverse severe fatty liver disease?
Disease control Recruiting nowThis study tests if weight-loss surgery is better than standard medical treatment for getting rid of nonalcoholic steatohepatitis (NASH) in obese people with advanced liver scarring. About 100 participants will be randomly assigned to either surgery or medical care. The main goal…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New MRI scan could spare NASH patients painful liver biopsies
Diagnosis Recruiting nowThis study is testing whether a special MRI scan called cT1 can accurately diagnose NASH (a serious liver disease) without needing a needle biopsy. About 225 adults who are already scheduled for a liver biopsy will also get this scan. If the scan works well, it could offer a safe…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: Perspectum • Aim: Diagnosis
Last updated May 11, 2026 20:51 UTC
-
Scientists probe hidden link between belly fat and liver damage
Knowledge-focused Recruiting nowThis study looks at how inflammation in fat tissue is connected to fat buildup in the liver and insulin resistance in people with severe obesity. Researchers will measure liver stiffness and markers of inflammation in 60 adults who are having gastric bypass surgery. The goal is t…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC